Not to restate the obvious, but I would asseverate Biogen of course HAS looked at AVXL, but if they made an offer of any type, it was deemed insufficient. Frankly, ANY BP that is not aware of hundreds of tiny companies working in this area, simply would not be doing their due diligence. It is going to be telling to see how many short arguments are made today, as a barometer of how concerned the short market is that AVXL is gaining traction. Now would be a lovely day to cover.
Market Data 
Markets 
